세계의 근위축성 측색 경화증 치료 시장(2025-2029년)

The amyotrophic lateral sclerosis treatment market is forecasted to grow by USD 207.5 mn during 2024-2029, accelerating at a CAGR of 4.8% during the forecast period. The report on the amyotrophic lateral sclerosis treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in incidence and prevalence of amyotrophic lateral sclerosis, huge unmet need for amyotrophic lateral sclerosis, and high research funding on amyotrophic lateral sclerosis treatment.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's amyotrophic lateral sclerosis treatment market is segmented as below:

By Type

• Intravenous
• Oral

By Distribution Channel

• Hospital pharmacies
• Retail pharmacies
• Online pharmacies

By Drug Class

• Riluzole
• Symptomatic treatments
• Edaravone
• Muscle relaxants
• Antisense oligonucleotides

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the increase in aging population as one of the prime reasons driving the amyotrophic lateral sclerosis treatment market growth during the next few years. Also, development of novel drugs for treatment of amyotrophic lateral sclerosis and rising funding in healthcare industry will lead to sizable demand in the market.

The report on the amyotrophic lateral sclerosis treatment market covers the following areas:

• Amyotrophic Lateral Sclerosis Treatment Market sizing
• Amyotrophic Lateral Sclerosis Treatment Market forecast
• Amyotrophic Lateral Sclerosis Treatment Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading amyotrophic lateral sclerosis treatment market vendors that include AB Science SA, Alkem Laboratories Ltd., Apotex Inc., Aquestive Therapeutics Inc, Biogen Inc., Brainstorm Cell Therapeutics Inc., CORESTEM Inc., Denali Therapeutics Inc., DR Reddys Laboratories Ltd., Eledon Pharmaceuticals, Ionis Pharmaceuticals Inc., Italfarmaco Holding SPA, Medindia Health, Mitsubishi Chemical Group Corp., Otsuka Holdings Co. Ltd., Revalesio Corp., Sanofi SA, Sun Pharmaceutical Industries Ltd., and Treeway BV. Also, the amyotrophic lateral sclerosis treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Executive Summary - Chart on Market Segmentation by Drug Class
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
  • Overview on criticality of inputs and factors of differentiation
• 2.3 Factors of disruption
  • Overview on factors of disruption
• 2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

• 3.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 3.2 Market characteristics
  • Market characteristics analysis
• 3.3 Value chain analysis
  • Value chain analysis

4 Market Sizing

• 4.1 Market definition
  • Offerings of companies included in the market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2024
• 4.4 Market outlook: Forecast for 2024-2029
  • Chart on Global - Market size and forecast 2024-2029 ($ million)
  • Data Table on Global - Market size and forecast 2024-2029 ($ million)
  • Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

• 5.1 Global Amyotrophic Lateral Sclerosis Treatment Market 2019 - 2023
  • Historic Market Size - Data Table on Global Amyotrophic Lateral Sclerosis Treatment Market 2019 - 2023 ($ million)
• 5.2 Type segment analysis 2019 - 2023
  • Historic Market Size - Type Segment 2019 - 2023 ($ million)
• 5.3 Distribution Channel segment analysis 2019 - 2023
  • Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
• 5.4 Drug Class segment analysis 2019 - 2023
  • Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
• 5.5 Geography segment analysis 2019 - 2023
  • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
• 5.6 Country segment analysis 2019 - 2023
  • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

• 6.1 The AI impact on Global Amyotrophic Lateral Sclerosis Treatment Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2024 and 2029
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2024 and 2029
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2024 and 2029
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2024 and 2029
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2024 and 2029
• 7.7 Market condition
  • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Type

• 8.1 Market segments
  • Chart on Type - Market share 2024-2029 (%)
  • Data Table on Type - Market share 2024-2029 (%)
• 8.2 Comparison by Type
  • Chart on Comparison by Type
  • Data Table on Comparison by Type
• 8.3 Intravenous - Market size and forecast 2024-2029
  • Chart on Intravenous - Market size and forecast 2024-2029 ($ million)
  • Data Table on Intravenous - Market size and forecast 2024-2029 ($ million)
  • Chart on Intravenous - Year-over-year growth 2024-2029 (%)
  • Data Table on Intravenous - Year-over-year growth 2024-2029 (%)
• 8.4 Oral - Market size and forecast 2024-2029
  • Chart on Oral - Market size and forecast 2024-2029 ($ million)
  • Data Table on Oral - Market size and forecast 2024-2029 ($ million)
  • Chart on Oral - Year-over-year growth 2024-2029 (%)
  • Data Table on Oral - Year-over-year growth 2024-2029 (%)
• 8.5 Market opportunity by Type
  • Market opportunity by Type ($ million)
  • Data Table on Market opportunity by Type ($ million)

9 Market Segmentation by Distribution Channel

• 9.1 Market segments
  • Chart on Distribution Channel - Market share 2024-2029 (%)
  • Data Table on Distribution Channel - Market share 2024-2029 (%)
• 9.2 Comparison by Distribution Channel
  • Chart on Comparison by Distribution Channel
  • Data Table on Comparison by Distribution Channel
• 9.3 Hospital pharmacies - Market size and forecast 2024-2029
  • Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
  • Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
  • Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
  • Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
• 9.4 Retail pharmacies - Market size and forecast 2024-2029
  • Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
  • Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
  • Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
  • Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
• 9.5 Online pharmacies - Market size and forecast 2024-2029
  • Chart on Online pharmacies - Market size and forecast 2024-2029 ($ million)
  • Data Table on Online pharmacies - Market size and forecast 2024-2029 ($ million)
  • Chart on Online pharmacies - Year-over-year growth 2024-2029 (%)
  • Data Table on Online pharmacies - Year-over-year growth 2024-2029 (%)
• 9.6 Market opportunity by Distribution Channel
  • Market opportunity by Distribution Channel ($ million)
  • Data Table on Market opportunity by Distribution Channel ($ million)

10 Market Segmentation by Drug Class

• 10.1 Market segments
  • Chart on Drug Class - Market share 2024-2029 (%)
  • Data Table on Drug Class - Market share 2024-2029 (%)
• 10.2 Comparison by Drug Class
  • Chart on Comparison by Drug Class
  • Data Table on Comparison by Drug Class
• 10.3 Riluzole - Market size and forecast 2024-2029
  • Chart on Riluzole - Market size and forecast 2024-2029 ($ million)
  • Data Table on Riluzole - Market size and forecast 2024-2029 ($ million)
  • Chart on Riluzole - Year-over-year growth 2024-2029 (%)
  • Data Table on Riluzole - Year-over-year growth 2024-2029 (%)
• 10.4 Symptomatic treatments - Market size and forecast 2024-2029
  • Chart on Symptomatic treatments - Market size and forecast 2024-2029 ($ million)
  • Data Table on Symptomatic treatments - Market size and forecast 2024-2029 ($ million)
  • Chart on Symptomatic treatments - Year-over-year growth 2024-2029 (%)
  • Data Table on Symptomatic treatments - Year-over-year growth 2024-2029 (%)
• 10.5 Edaravone - Market size and forecast 2024-2029
  • Chart on Edaravone - Market size and forecast 2024-2029 ($ million)
  • Data Table on Edaravone - Market size and forecast 2024-2029 ($ million)
  • Chart on Edaravone - Year-over-year growth 2024-2029 (%)
  • Data Table on Edaravone - Year-over-year growth 2024-2029 (%)
• 10.6 Muscle relaxants - Market size and forecast 2024-2029
  • Chart on Muscle relaxants - Market size and forecast 2024-2029 ($ million)
  • Data Table on Muscle relaxants - Market size and forecast 2024-2029 ($ million)
  • Chart on Muscle relaxants - Year-over-year growth 2024-2029 (%)
  • Data Table on Muscle relaxants - Year-over-year growth 2024-2029 (%)
• 10.7 Antisense oligonucleotides - Market size and forecast 2024-2029
  • Chart on Antisense oligonucleotides - Market size and forecast 2024-2029 ($ million)
  • Data Table on Antisense oligonucleotides - Market size and forecast 2024-2029 ($ million)
  • Chart on Antisense oligonucleotides - Year-over-year growth 2024-2029 (%)
  • Data Table on Antisense oligonucleotides - Year-over-year growth 2024-2029 (%)
• 10.8 Market opportunity by Drug Class
  • Market opportunity by Drug Class ($ million)
  • Data Table on Market opportunity by Drug Class ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Data Table on Market share By Geographical Landscape 2024-2029 (%)
• 12.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 12.3 North America - Market size and forecast 2024-2029
  • Chart on North America - Market size and forecast 2024-2029 ($ million)
  • Data Table on North America - Market size and forecast 2024-2029 ($ million)
  • Chart on North America - Year-over-year growth 2024-2029 (%)
  • Data Table on North America - Year-over-year growth 2024-2029 (%)
• 12.4 Europe - Market size and forecast 2024-2029
  • Chart on Europe - Market size and forecast 2024-2029 ($ million)
  • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  • Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Data Table on Europe - Year-over-year growth 2024-2029 (%)
• 12.5 Asia - Market size and forecast 2024-2029
  • Chart on Asia - Market size and forecast 2024-2029 ($ million)
  • Data Table on Asia - Market size and forecast 2024-2029 ($ million)
  • Chart on Asia - Year-over-year growth 2024-2029 (%)
  • Data Table on Asia - Year-over-year growth 2024-2029 (%)
• 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
  • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
• 12.7 US - Market size and forecast 2024-2029
  • Chart on US - Market size and forecast 2024-2029 ($ million)
  • Data Table on US - Market size and forecast 2024-2029 ($ million)
  • Chart on US - Year-over-year growth 2024-2029 (%)
  • Data Table on US - Year-over-year growth 2024-2029 (%)
• 12.8 Germany - Market size and forecast 2024-2029
  • Chart on Germany - Market size and forecast 2024-2029 ($ million)
  • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  • Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Data Table on Germany - Year-over-year growth 2024-2029 (%)
• 12.9 China - Market size and forecast 2024-2029
  • Chart on China - Market size and forecast 2024-2029 ($ million)
  • Data Table on China - Market size and forecast 2024-2029 ($ million)
  • Chart on China - Year-over-year growth 2024-2029 (%)
  • Data Table on China - Year-over-year growth 2024-2029 (%)
• 12.10 UK - Market size and forecast 2024-2029
  • Chart on UK - Market size and forecast 2024-2029 ($ million)
  • Data Table on UK - Market size and forecast 2024-2029 ($ million)
  • Chart on UK - Year-over-year growth 2024-2029 (%)
  • Data Table on UK - Year-over-year growth 2024-2029 (%)
• 12.11 Canada - Market size and forecast 2024-2029
  • Chart on Canada - Market size and forecast 2024-2029 ($ million)
  • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
  • Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Data Table on Canada - Year-over-year growth 2024-2029 (%)
• 12.12 France - Market size and forecast 2024-2029
  • Chart on France - Market size and forecast 2024-2029 ($ million)
  • Data Table on France - Market size and forecast 2024-2029 ($ million)
  • Chart on France - Year-over-year growth 2024-2029 (%)
  • Data Table on France - Year-over-year growth 2024-2029 (%)
• 12.13 Japan - Market size and forecast 2024-2029
  • Chart on Japan - Market size and forecast 2024-2029 ($ million)
  • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  • Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Data Table on Japan - Year-over-year growth 2024-2029 (%)
• 12.14 Italy - Market size and forecast 2024-2029
  • Chart on Italy - Market size and forecast 2024-2029 ($ million)
  • Data Table on Italy - Market size and forecast 2024-2029 ($ million)
  • Chart on Italy - Year-over-year growth 2024-2029 (%)
  • Data Table on Italy - Year-over-year growth 2024-2029 (%)
• 12.15 India - Market size and forecast 2024-2029
  • Chart on India - Market size and forecast 2024-2029 ($ million)
  • Data Table on India - Market size and forecast 2024-2029 ($ million)
  • Chart on India - Year-over-year growth 2024-2029 (%)
  • Data Table on India - Year-over-year growth 2024-2029 (%)
• 12.16 Spain - Market size and forecast 2024-2029
  • Chart on Spain - Market size and forecast 2024-2029 ($ million)
  • Data Table on Spain - Market size and forecast 2024-2029 ($ million)
  • Chart on Spain - Year-over-year growth 2024-2029 (%)
  • Data Table on Spain - Year-over-year growth 2024-2029 (%)
• 12.17 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

• 13.1 Market drivers
• 13.2 Market challenges
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029
• 13.4 Market opportunities/restraints

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 AB Science SA
  • AB Science SA - Overview
  • AB Science SA - Product / Service
  • AB Science SA - Key offerings
  • SWOT
• 15.5 Alkem Laboratories Ltd.
  • Alkem Laboratories Ltd. - Overview
  • Alkem Laboratories Ltd. - Business segments
  • Alkem Laboratories Ltd. - Key offerings
  • Alkem Laboratories Ltd. - Segment focus
  • SWOT
• 15.6 Aquestive Therapeutics Inc
  • Aquestive Therapeutics Inc - Overview
  • Aquestive Therapeutics Inc - Product / Service
  • Aquestive Therapeutics Inc - Key offerings
  • SWOT
• 15.7 Biogen Inc.
  • Biogen Inc. - Overview
  • Biogen Inc. - Product / Service
  • Biogen Inc. - Key offerings
  • SWOT
• 15.8 Brainstorm Cell Therapeutics Inc.
  • Brainstorm Cell Therapeutics Inc. - Overview
  • Brainstorm Cell Therapeutics Inc. - Product / Service
  • Brainstorm Cell Therapeutics Inc. - Key offerings
  • SWOT
• 15.9 CORESTEM Inc.
  • CORESTEM Inc. - Overview
  • CORESTEM Inc. - Product / Service
  • CORESTEM Inc. - Key offerings
  • SWOT
• 15.10 Denali Therapeutics Inc.
  • Denali Therapeutics Inc. - Overview
  • Denali Therapeutics Inc. - Product / Service
  • Denali Therapeutics Inc. - Key offerings
  • SWOT
• 15.11 Eledon Pharmaceuticals
  • Eledon Pharmaceuticals - Overview
  • Eledon Pharmaceuticals - Product / Service
  • Eledon Pharmaceuticals - Key offerings
  • SWOT
• 15.12 Ionis Pharmaceuticals Inc.
  • Ionis Pharmaceuticals Inc. - Overview
  • Ionis Pharmaceuticals Inc. - Product / Service
  • Ionis Pharmaceuticals Inc. - Key news
  • Ionis Pharmaceuticals Inc. - Key offerings
  • SWOT
• 15.13 Italfarmaco Holding SPA
  • Italfarmaco Holding SPA - Overview
  • Italfarmaco Holding SPA - Product / Service
  • Italfarmaco Holding SPA - Key offerings
  • SWOT
• 15.14 Mitsubishi Chemical Group Corp.
  • Mitsubishi Chemical Group Corp. - Overview
  • Mitsubishi Chemical Group Corp. - Business segments
  • Mitsubishi Chemical Group Corp. - Key news
  • Mitsubishi Chemical Group Corp. - Key offerings
  • Mitsubishi Chemical Group Corp. - Segment focus
  • SWOT
• 15.15 Revalesio Corp.
  • Revalesio Corp. - Overview
  • Revalesio Corp. - Product / Service
  • Revalesio Corp. - Key offerings
  • SWOT
• 15.16 Sanofi SA
  • Sanofi SA - Overview
  • Sanofi SA - Business segments
  • Sanofi SA - Key news
  • Sanofi SA - Key offerings
  • Sanofi SA - Segment focus
  • SWOT
• 15.17 Sun Pharmaceutical Industries Ltd.
  • Sun Pharmaceutical Industries Ltd. - Overview
  • Sun Pharmaceutical Industries Ltd. - Product / Service
  • Sun Pharmaceutical Industries Ltd. - Key news
  • Sun Pharmaceutical Industries Ltd. - Key offerings
  • SWOT
• 15.18 Treeway BV
  • Treeway BV - Overview
  • Treeway BV - Product / Service
  • Treeway BV - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations